Mutation analysis of the 8p22 candidate tumor suppressor gene ATIP/MTUS1 in hepatocellular carcinoma.
about
8p22 MTUS1 gene product ATIP3 is a novel anti-mitotic protein underexpressed in invasive breast carcinoma of poor prognosisEffect of angiotensin II type 2 receptor-interacting protein on adipose tissue function via modulation of macrophage polarizationMicrotubule associated tumor suppressor 1 deficient mice develop spontaneous heart hypertrophy and SLE-like lymphoproliferative diseaseGlobal gene profiling of spontaneous hepatocellular carcinoma in B6C3F1 mice: similarities in the molecular landscape with human liver cancerA human genome-wide library of local phylogeny predictions for whole-genome inference problemsMolecular cytogenetic characterization of canine histiocytic sarcoma: A spontaneous model for human histiocytic cancer identifies deletion of tumor suppressor genes and highlights influence of genetic background on tumor behavior.Copy number variant in the candidate tumor suppressor gene MTUS1 and familial breast cancer risk.Frequent loss of heterozygosity in two distinct regions, 8p23.1 and 8p22, in hepatocellular carcinoma.The mutational landscapes of genetic and chemical models of Kras-driven lung cancerGenomic imbalances in esophageal carcinoma cell lines involve Wnt pathway genesLoss of MTUS1/ATIP expression is associated with adverse outcome in advanced bladder carcinomas: data from a retrospective study.MTUS1/ATIP3a down-regulation is associated with enhanced migration, invasion and poor prognosis in salivary adenoid cystic carcinomaLipoprotein lipase as a candidate target for cancer prevention/therapyDown-regulation of tumor suppressor MTUS1/ATIP is associated with enhanced proliferation, poor differentiation and poor prognosis in oral tongue squamous cell carcinomaAngiotensin II type 2 receptor-interacting protein 3a suppresses proliferation, migration and invasion in tongue squamous cell carcinoma via the extracellular signal-regulated kinase-Snai2 pathwayIdentification of the Mtus1 Splice Variant as a Novel Inhibitory Factor Against Cardiac Hypertrophy.Genomic assessments of the frequent loss of heterozygosity region on 8p21.3-p22 in head and neck squamous cell carcinoma.Angiotensin II type 2 receptor-interacting protein 3a inhibits ovarian carcinoma metastasis via the extracellular HMGA2-mediated ERK/EMT pathway.Gene sequencing and tissue expression of unknown isoforms of an angiotensin II type 2 receptor interacting protein, ATIP, in the rat.The Expression of MTUS1/ATIP and Its Major Isoforms, ATIP1 and ATIP3, in Human Prostate CancerFrequent loss of heterozygosity at 8p22 chromosomal region in diffuse type of gastric cancer.Expression and role of the angiotensin II AT2 receptor in human prostate tissue: in search of a new therapeutic option for prostate cancer.Long noncoding RNA TSLNC8 is a tumor suppressor that inactivates the interleukin-6/STAT3 signaling pathway.
P2860
Q27340316-A3409395-9E90-42B7-84DB-44D0418EDBF5Q28584994-BA9F4247-90D4-4AFB-BC7B-0CD5863ED0A0Q28591529-66615F47-BE06-4E7F-BD2D-B6148AEBE298Q28829385-08655B9E-D4A4-40B7-AC0B-40FBE92908D1Q33361051-A3D3CC21-C22E-441F-87E1-5C1D14D12EA7Q33912955-8F313C0F-F91A-49D4-BA39-DDB4F618A352Q34002454-9E2A846E-90D8-43C3-A473-C225D6BD38FCQ34099045-81675853-6FBE-49AA-A401-4AA990A2438EQ35007114-968A8766-FC1B-4611-84E5-1593B5E55612Q35085978-FDD9BC58-B63F-4D10-B048-95BC7FB15070Q35125879-92C0930A-CA87-4473-AE2C-8DA2A0CCCF82Q35368044-706A7068-423A-4896-BFF3-353CC935B6A3Q35418859-87456C55-DC42-4729-A182-F00145279626Q35712864-2B89F4BD-F9E2-4874-9A16-00D710B16960Q36502514-78E53995-C135-4B5D-A545-B05253B8434AQ37240712-9B47D2BE-9F7A-4EF1-A80B-660B096B2FA4Q38299702-A1719591-436D-4A6D-ADFB-0B21123B78B9Q38699001-1FE2D414-04DF-476C-822C-338B67CA53B9Q39578595-A6A48E3E-7B91-439C-9E49-0B3A6F9CC735Q42448400-217D05FC-19AC-4742-9D0C-209286442ABCQ42911521-4BBECA38-92A0-4708-8A12-B7A5D61448C5Q43880703-3FCCF778-19D6-43F4-BD77-C7EC0DDFBFB1Q48024895-3DF909AD-DE45-418B-BA1D-A8EB441CAB81
P2860
Mutation analysis of the 8p22 candidate tumor suppressor gene ATIP/MTUS1 in hepatocellular carcinoma.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Mutation analysis of the 8p22 ...... 1 in hepatocellular carcinoma.
@ast
Mutation analysis of the 8p22 ...... 1 in hepatocellular carcinoma.
@en
Mutation analysis of the 8p22 ...... 1 in hepatocellular carcinoma.
@nl
type
label
Mutation analysis of the 8p22 ...... 1 in hepatocellular carcinoma.
@ast
Mutation analysis of the 8p22 ...... 1 in hepatocellular carcinoma.
@en
Mutation analysis of the 8p22 ...... 1 in hepatocellular carcinoma.
@nl
prefLabel
Mutation analysis of the 8p22 ...... 1 in hepatocellular carcinoma.
@ast
Mutation analysis of the 8p22 ...... 1 in hepatocellular carcinoma.
@en
Mutation analysis of the 8p22 ...... 1 in hepatocellular carcinoma.
@nl
P2093
P1476
Mutation analysis of the 8p22 ...... 1 in hepatocellular carcinoma.
@en
P2093
Berhouet S
Couraud PO
Di Benedetto M
Stoppa-Lyonnet D
P304
P356
10.1016/J.MCE.2006.03.014
P577
2006-05-02T00:00:00Z